Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 >>

4 March 2015: UCL alumna awarded Professional Achievement Award by British Council

Tina Liu (UCL Centre for Transport Studies, 2010) has been announced as the winner of this year’s Professional Achievement Award in the Education UK Alumni Awards for China run by the British Council. More...

3 March 2015: Could this UCL alumnus be the next Mark Zuckerberg?

Julia Pimentel interviews Ricardo Mighty, UCL Alumnus and founder of PinU More...

<< 2014 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2016 >>